DETERMINATION OF POOR GLYCEMIC CONTROL RATE AND RELATED FACTORS IN OUTPATIENTS WITH TYPE 2 DIABETES AT THU DUC GENERAL HOSPITAL

Vu Tri Thanh1, Ngo The Phi1, Nguyen Thi Thu Thuy1, Dao Dac Duc1
1 Thu Duc General Hospital

Main Article Content

Abstract

Objective: To determine the rate of poor glycemic control among outpatients with type 2 diabetes at Thu Duc General Hospital and to evaluate some related factors.


Subjects and methods: A cross-sectional descriptive study was conducted on 355 patients with type 2 diabetes mellitus receiving outpatient treatment and follow-up between May and December 2024. The study sites included endocrinology, cardiology, family medicine, and internal medicine clinics. Patients with communication or cognitive impairments, as well as those with medical conditions affecting HbA1c test accuracy, were excluded from the study.


Results: The mean age was 59.7 ± 11.96 years (range: 21-91), with the majority aged 51-70 years (63.9%). Females accounted for 56.2%. The mean duration of diabetes was 7.9 years. Overweight/obesity was observed in 34.7%, and central obesity in 70.4% (66% in females). Most patients were treated with oral hypoglycemic agents alone (83.1%), 14.9% received combined oral drugs and Insulin, and 2% used Insulin only. Overall, 16.9% of patients were on Insulin therapy. Regarding adherence, 12.4% adhered well, 37.2% poorly, and more than 50% moderately. Good adherence to dietary recommendations and physical activity was reported in 47.3% and 38.9%, respectively. Poor glycemic control (HbA1c ≥ 7%) was found in 57.5% of patients, with 56.1% failing to achieve fasting glucose targets. Chi-square analysis revealed a significant association between treatment adherence (medication, diet, exercise) and glycemic control (p = 0.001).


Conclusion: Glycemic control among outpatients with type 2 diabetes at Thu Duc General Hospital was more favorable compared to some other domestic studies. Duration of diabetes, medication adherence, diet, and physical activity were strongly associated with glycemic outcomes.

Article Details

References

[1] American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: standards of care in diabetes, 2024. Diabetes Care, 2024, 47 (Supplement_1): S158-S178. doi: 10.2337/dc24-S009.
[2] Nguyen T.K et al. A cross-sectional study to evaluate diabetes management, control and complications in 1631 patients with type 2 diabetes mellitus in Vietnam (DiabCare Asia). International Journal of Diabetes in Developing Countries, 2019, 40 (Suppl 1): 70079. doi:10.1007/s13410-019-00755-w
[3] Haghighatpanah M, Nejad A.S.M, Haghighatpanah M, Thunga G, Mallayasamy S. Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong Public Health Res Perspect, 2018, 9 (4): 167-174. doi: 10.24171/j.phrp.2018.9.4.05.
[4] Shah S, Barot P, Patel H, Shukla A. Assessment of medication adherence in diabetes mellitus patients at a tertiary care teaching hospital in India. Cureus, 2025, 17 (2): e78391. doi: 10.7759/cureus.78391.
[5] Suprapti B, Izzah Z, Anjani A.G, Andarsari M.R, Nilamsari W.P, Nugroho C.W. Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: a cross-sectional study. Glob Epidemiol, 2023, 5: 100113. doi: 10.1016/j.gloepi.2023.100113.